Catalyst Wire Dossier Catalyst Wire Dossier

tafluprost-timolol fixed combination

tafluprost-timolol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for tafluprost-timolol fixed combination, covering 2022-03-29 to 2022-03-29. Get the full timeline:

Most recent: Clinical Trial Update: 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. [Phase 4]

See pricing